Clinical Trial Update: Long-acting Naltrexone for Pre-release Prisoners [Phase 3]

View source ↗

Summary

A Phase 3 trial of long-acting naltrexone for opioid use disorder in pre-release prisoners has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Friends Research Institute, Inc. | Conditions: Opiate Addiction | Phase 3 | Status: COMPLETED